Ferritinemia in ovarian malignant tumours

other public-domain-us
View on PubMed
AI-generated summary by claude@2026-06, 2026-06-13

Ferritin levels were elevated in ovarian endometrioid tumors and active disease, with increased ferritin/sideremia ratios and non-concanavallin A-bound ferritin suggesting direct release by tumor cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Seriated ferritin assays were carried out on 95 patients affected by primitive ovarian epithelial tumour over a period of three years (1979/82), by radioimmunometric assay for human spleen ferritin. Ferritin was elevated in endometrioid tumours and in the presence of active progressing disease and chemotherapy did not influence these values. The ferritin/sideremia ratio was high in the case with pathological levels. Studying the glicosilation of this protein a significant amount of ferritin was not bound to concavallin A, suggesting direct release of this protein by tumour cells.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Ferritins Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma, Mucinous Adenocarcinoma, Mucinous Carcinoma Carcinoma Endometriosis Endometriosis Female Ferritins Follow-Up Studies Humans Iron Iron Mesonephroma Mesonephroma Neoplasm Staging Ovarian Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-21T06:12:49.409960+00:00
pubmed
last seen: 2026-05-13T22:10:00.881616+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine